Drug recall D-0489-2025
Product
DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62
Reason for recall
Discoloration; discolored solution from cracked vials
Lots and codes
Lot KA5023, exp 02/28/2026
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 98,410 vials
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 28, 2025
Related products
- Dobutamine – drug information
- NDC 0409-2344 Dobutamine · Dobutamine Hydrochloride 12.5 mg/mL · Hospira, Inc.